$CAPR
CAPRICOR THERAPEUTICS, INC.

2014 Q2 Form 10-Q Financial Statement

#000114420414031429 Filed on May 15, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2014 Q1 2013 Q1
Revenue $1.042M $1.042M $233.3K
YoY Change 449.66% 346.51% 19.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $660.0K $850.0K $470.0K
YoY Change 34.69% 80.85% -6.0%
% of Gross Profit
Research & Development $1.856M $1.375M $1.191M
YoY Change 41.51% 15.41% 155.97%
% of Gross Profit
Depreciation & Amortization $10.00K $6.465K $6.120K
YoY Change 5.64% 241.33%
% of Gross Profit
Operating Expenses $2.522M $2.227M $1.666M
YoY Change 39.76% 33.71% 72.53%
Operating Profit -$1.480M -$1.185M -$1.432M
YoY Change -8.34% -17.23% 86.04%
Interest Expense $54.70K $25.33K $3.711K
YoY Change 780.76% 582.48%
% of Operating Profit
Other Income/Expense, Net -$53.51K -$25.17K $15.18K
YoY Change 464.25% -265.86% -856.63%
Pretax Income -$1.530M -$1.210M -$1.420M
YoY Change -5.56% -14.79% 84.42%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.534M -$1.211M -$1.417M
YoY Change -5.58% -14.57% 83.59%
Net Earnings / Revenue -147.26% -116.22% -607.44%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.297M -$1.034M -$1.365M
COMMON SHARES
Basic Shares Outstanding 11.69M shares 11.69M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.91M $13.31M $290.0K
YoY Change 5077.38% 4488.06% -34.09%
Cash & Equivalents $11.58M $12.98M $282.2K
Short-Term Investments $325.8K $326.2K $10.00K
Other Short-Term Assets $4.500M $730.0K $110.0K
YoY Change 7400.0% 563.64% -50.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $16.41M $14.03M $400.0K
YoY Change 5572.45% 3407.74% -39.04%
LONG-TERM ASSETS
Property, Plant & Equipment $204.0K $163.5K $0.00
YoY Change 20423.44% -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $60.00K $50.00K $10.00K
YoY Change 1223.04% 400.0% -80.75%
Total Long-Term Assets $2.027M $1.946M $20.00K
YoY Change 36569.45% 9628.8% -66.6%
TOTAL ASSETS
Total Short-Term Assets $16.41M $14.03M $400.0K
Total Long-Term Assets $2.027M $1.946M $20.00K
Total Assets $18.44M $15.98M $420.0K
YoY Change 6153.76% 3703.98% -41.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.180M $2.000M $260.0K
YoY Change 448.32% 669.23% -20.53%
Accrued Expenses $140.0K $130.0K $200.0K
YoY Change -60.0% -35.0% 233.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $190.0K
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.492M $6.299M $650.0K
YoY Change 539.26% 869.12% 33.92%
LONG-TERM LIABILITIES
Long-Term Debt $8.640M $3.960M $0.00
YoY Change
Other Long-Term Liabilities $6.390M $7.380M $410.0K
YoY Change 1152.94% 1700.0%
Total Long-Term Liabilities $15.03M $11.34M $410.0K
YoY Change 2847.03% 2665.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.492M $6.299M $650.0K
Total Long-Term Liabilities $15.03M $11.34M $410.0K
Total Liabilities $21.52M $17.64M $1.060M
YoY Change 1308.82% 1563.79% 116.33%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $15.76M $11.69K
YoY Change 36496.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.085M -$1.659M -$640.0K
YoY Change
Total Liabilities & Shareholders Equity $18.44M $15.98M $420.0K
YoY Change 6153.76% 3703.98% -41.34%

Cashflow Statement

Concept 2014 Q2 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income -$1.534M -$1.211M -$1.417M
YoY Change -5.58% -14.57% 83.59%
Depreciation, Depletion And Amortization $10.00K $6.465K $6.120K
YoY Change 5.64% 241.33%
Cash From Operating Activities -$6.010M $11.34M -$1.180M
YoY Change 853.97% -1061.02% 95.54%
INVESTING ACTIVITIES
Capital Expenditures -$60.00K $92.90K $3.144K
YoY Change 20.0% 2854.87%
Acquisitions
YoY Change
Other Investing Activities $0.00 $2.257K $450.0K
YoY Change -100.0% -99.5%
Cash From Investing Activities -$70.00K -$90.00K $430.0K
YoY Change -107.22% -120.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.690M 0.000 860.0K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -6.010M 11.34M -1.180M
Cash From Investing Activities -70.00K -90.00K 430.0K
Cash From Financing Activities 4.690M 0.000 860.0K
Net Change In Cash -1.390M 11.25M 110.0K
YoY Change -508.82% 10127.27% -118.23%
FREE CASH FLOW
Cash From Operating Activities -$6.010M $11.34M -$1.180M
Capital Expenditures -$60.00K $92.90K $3.144K
Free Cash Flow -$5.950M $11.25M -$1.183M
YoY Change 925.86% -1050.61% 96.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-404 USD
CY2014Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
1500000 USD
CY2013Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
1500000 USD
CY2014Q1 us-gaap Assets
Assets
15976704 USD
CY2013Q4 us-gaap Assets
Assets
5537907 USD
CY2014Q1 capr Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
481643 USD
CY2013Q4 capr Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
382142 USD
CY2014Q1 us-gaap Liabilities
Liabilities
17636144 USD
CY2013Q4 us-gaap Liabilities
Liabilities
6072789 USD
CY2014Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <u>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures. Management uses its historical records and knowledge of its business in making these estimates. Accordingly, actual results may differ from these estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
187 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
169579 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
222763 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
14030944 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
3680840 USD
CY2014Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
326226 USD
CY2013Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
326494 USD
CY2014Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
555232 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1401859 USD
CY2014Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
757 USD
CY2014Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
38850 USD
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
38850 USD
CY2014Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
208667 USD
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
115766 USD
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
247517 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
154616 USD
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
83978 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
80429 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
163539 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
74187 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
228382 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
227207 USD
CY2014Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
28111 USD
CY2013Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
29945 USD
CY2014Q1 us-gaap Deposit Assets
DepositAssets
25728 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8763 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
576 USD
CY2014Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1518595 USD
CY2013Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1506509 USD
CY2013Q4 us-gaap Deposit Assets
DepositAssets
25728 USD
CY2014Q1 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
0 USD
CY2013Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
41855 USD
CY2014Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
132379 USD
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
122416 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6299284 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2052922 USD
CY2014Q1 us-gaap Loans Payable
LoansPayable
3961733 USD
CY2013Q4 us-gaap Loans Payable
LoansPayable
3961733 USD
CY2014Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
83461 USD
CY2013Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
58134 USD
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11690859 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
332281 shares
CY2014Q1 capr Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
0 shares
CY2014Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
332281 shares
CY2014Q1 capr Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
0
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1 pure
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.17 pure
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014Q1 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
11336860 USD
CY2013Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
4019867 USD
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
11690 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
11687 USD
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15638420 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15552946 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-404 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-980 USD
CY2014Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
17309146 USD
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
16098535 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
-1659440 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-534882 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15976704 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5537907 USD
CY2014Q1 us-gaap Marketable Securities
MarketableSecurities
326226 USD
CY2013Q4 us-gaap Marketable Securities
MarketableSecurities
326494 USD
CY2014Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-50
CY2013Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-50
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
1500000 USD
CY2013Q4 capr Number Of Rights Offer For Each Share As Per Merger Agreement
NumberOfRightsOfferForEachShareAsPerMergerAgreement
2.07 shares
CY2014Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
13300000 USD
CY2013Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
2100000 USD
CY2014Q1 capr Proceeds From Development Fee
ProceedsFromDevelopmentFee
12500000 USD
CY2013 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1900000 USD
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5813078 shares
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5041281 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.022 pure
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41373 USD
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
84544 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
750667 USD
CY2014Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.25
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.65
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11690859 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11687747 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11687747 shares
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
33557 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
32475 USD
CY2014Q1 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
8556 USD
CY2013Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
6722 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4888519 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
25362 shares
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3112 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4709000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2719483 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.51
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.00
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.30
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.58
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.65
CY2014Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
828035 USD
CY2014Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2014Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
13600000 USD
CY2014Q1 capr Leases Monthly Payments For First Twelve Months
LeasesMonthlyPaymentsForFirstTwelveMonths
16620 USD
CY2014Q1 capr Leases Monthly Payments For Second Twelve Months
LeasesMonthlyPaymentsForSecondTwelveMonths
17285 USD
CY2014Q1 capr Additional Milestone Payments To Be Received Contingent Upon Exercise Of Options
AdditionalMilestonePaymentsToBeReceivedContingentUponExerciseOfOptions
325000000 USD
CY2013Q1 us-gaap Revenue From Grants
RevenueFromGrants
233291 USD
CY2014Q1 us-gaap Revenue From Grants
RevenueFromGrants
0 USD
us-gaap Revenue From Grants
RevenueFromGrants
4180970 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1191154 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1374757 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12874352 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
474429 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
852347 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7806014 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
1665583 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
2227104 USD
us-gaap Operating Expenses
OperatingExpenses
20680366 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1432292 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1185437 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-15457729 USD
CY2013Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
18889 USD
CY2014Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
153 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
151044 USD
CY2013Q1 us-gaap Interest Expense
InterestExpense
3711 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
25327 USD
us-gaap Interest Expense
InterestExpense
83461 USD
CY2013Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2014Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1919000 USD
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15178 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25174 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1851417 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-1417114 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-1210611 USD
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10351294 shares
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11689441 shares
us-gaap Net Income Loss
NetIncomeLoss
-17309146 USD
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-8763 USD
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
576 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-404 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1425877 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1210035 USD
CY2012 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-21795 USD
CY2013 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
20815 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
576 USD
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-1171419 USD
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-979076 USD
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-630859 USD
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-148970 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-17309550 USD
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-1055748 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-1149320 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-2071255 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-8891924 USD
us-gaap Net Income Loss
NetIncomeLoss
36 USD
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
1836495 USD
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
863168 USD
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
252552 USD
CY2005Q3 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2006 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3008000 USD
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000000 USD
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2008 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
3858 USD
CY2009 capr Stock And Warrants Issued For Cash Value
StockAndWarrantsIssuedForCashValue
800007 USD
CY2010 capr Stock And Warrants Issued For Cash Value
StockAndWarrantsIssuedForCashValue
2000000 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
91155 USD
CY2006 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
86 USD
CY2007 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
71 USD
CY2008 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
37 USD
CY2009 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
69 USD
CY2010 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
57 USD
CY2011 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
29 USD
CY2012 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
26 USD
CY2013 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
1 USD
capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
36 USD
CY2013 capr Proceeds From Subscription Receivables
ProceedsFromSubscriptionReceivables
2212 USD
CY2007 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5820 USD
CY2008 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16422 USD
CY2009 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8251 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24163 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15527 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
332347 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
263593 USD
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
84544 USD
CY2013 capr Stock Issued During Period Value For Reverse Merger Transaction
StockIssuedDuringPeriodValueForReverseMergerTransaction
3176000 USD
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
911771 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
1788974 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
1655152 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
4894423 USD
CY2005Q4 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2013Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2014Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3707 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6120 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6465 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
171197 USD
CY2013Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2014Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
3858 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
41373 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
84544 USD
us-gaap Share Based Compensation
ShareBasedCompensation
750667 USD
CY2013Q1 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
515222 USD
CY2014Q1 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-846627 USD
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
555232 USD
CY2013Q1 capr Increase Decrease From Grants Receivable
IncreaseDecreaseFromGrantsReceivable
-329240 USD
CY2014Q1 capr Increase Decrease From Grants Receivable
IncreaseDecreaseFromGrantsReceivable
0 USD
capr Increase Decrease From Grants Receivable
IncreaseDecreaseFromGrantsReceivable
0 USD
CY2013Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-8274 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
570 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
757 USD
CY2013Q1 capr Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
-7268 USD
CY2014Q1 capr Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
-53184 USD
capr Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
146475 USD
CY2013Q1 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
0 USD
CY2014Q1 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
0 USD
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
23193 USD
CY2013Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
165058 USD
CY2014Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
12086 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1251092 USD
CY2013Q1 capr Increase Decrease In Accounts Payable And Accrued Expenses Related Party
IncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedParty
133094 USD
CY2014Q1 capr Increase Decrease In Accounts Payable And Accrued Expenses Related Party
IncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedParty
99501 USD
capr Increase Decrease In Accounts Payable And Accrued Expenses Related Party
IncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedParty
481643 USD
CY2013Q1 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
48317 USD
CY2014Q1 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
-41855 USD
us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
0 USD
CY2013Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
9963 USD
CY2014Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
9963 USD
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
132379 USD
CY2013Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3711 USD
CY2014Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
25327 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
83461 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1176207 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
11342994 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1786880 USD
CY2013Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
42830 USD
CY2014Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
226998 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
4668517 USD
CY2013Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
488000 USD
CY2014Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
227842 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
4341887 USD
CY2013Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2014Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
88908 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3144 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
92901 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
377824 USD
CY2013Q1 capr Proceeds From Reverse Merger
ProceedsFromReverseMerger
0 USD
CY2014Q1 capr Proceeds From Reverse Merger
ProceedsFromReverseMerger
0 USD
capr Proceeds From Reverse Merger
ProceedsFromReverseMerger
-664 USD
CY2013Q1 capr Payments For Patents
PaymentsForPatents
10986 USD
CY2014Q1 capr Payments For Patents
PaymentsForPatents
2257 USD
capr Payments For Patents
PaymentsForPatents
261939 USD
CY2013Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
431040 USD
CY2014Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-94314 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-876821 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
857267 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3925066 USD
CY2013Q1 capr Payment Of Preferred Stock And Warrant Issuance Cost
PaymentOfPreferredStockAndWarrantIssuanceCost
0 USD
CY2014Q1 capr Payment Of Preferred Stock And Warrant Issuance Cost
PaymentOfPreferredStockAndWarrantIssuanceCost
0 USD
capr Payment Of Preferred Stock And Warrant Issuance Cost
PaymentOfPreferredStockAndWarrantIssuanceCost
91155 USD
CY2013Q1 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
857267 USD
CY2014Q1 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
933 USD
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
15642851 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
112100 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
11249613 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12979150 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
170106 USD
CY2005Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
282206 USD
CY2013Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
CY2013Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2014Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Trading Symbol
TradingSymbol
CAPR
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11690859 shares
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
CAPRICOR THERAPEUTICS, INC.
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001133869
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4166667 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2014Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
7291666 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 USD
CY2014Q1 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2013Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q1 capr Collaboration Revenue
CollaborationRevenue
0 USD
CY2014Q1 capr Collaboration Revenue
CollaborationRevenue
1041667 USD
capr Collaboration Revenue
CollaborationRevenue
1041667 USD
CY2013Q1 us-gaap Revenues
Revenues
233291 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Revenues
Revenues
1041667 USD
us-gaap Revenues
Revenues
5222637 USD
CY2013Q1 capr Proceeds From Stock Option Exercises
ProceedsFromStockOptionExercises
0 USD
CY2014Q1 capr Proceeds From Stock Option Exercises
ProceedsFromStockOptionExercises
933 USD
capr Proceeds From Stock Option Exercises
ProceedsFromStockOptionExercises
933 USD
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q1 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
3711 USD
CY2014Q1 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
11458333 USD
us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
11458333 USD
CY2014Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
933 USD
CY2014Q1 us-gaap Payments For Royalties
PaymentsForRoyalties
20000 EUR
CY2014Q1 us-gaap Reimbursement Revenue
ReimbursementRevenue
1550000 USD
CY2012Q1 us-gaap Reimbursement Revenue
ReimbursementRevenue
195500 USD
CY2014Q1 capr Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
CY2014Q1 capr Class Of Warrant Or Right Exercised Weighted Average Exercise Price
ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice
0
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
201769 shares
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.30
CY2014Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
6591494 shares
CY2013Q4 capr Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
17.20
CY2014Q1 capr Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
17.20

Files In Submission

Name View Source Status
0001144204-14-031429-index-headers.html Edgar Link pending
0001144204-14-031429-index.html Edgar Link pending
0001144204-14-031429.txt Edgar Link pending
0001144204-14-031429-xbrl.zip Edgar Link pending
capr-20140331.xml Edgar Link completed
capr-20140331.xsd Edgar Link pending
capr-20140331_cal.xml Edgar Link unprocessable
capr-20140331_def.xml Edgar Link unprocessable
capr-20140331_lab.xml Edgar Link unprocessable
capr-20140331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpg56.jpg Edgar Link pending
tpg58.jpg Edgar Link pending
tpg65.jpg Edgar Link pending
v377873_10q.htm Edgar Link pending
v377873_ex10-1.htm Edgar Link pending
v377873_ex31-1.htm Edgar Link pending
v377873_ex31-2.htm Edgar Link pending
v377873_ex32-1.htm Edgar Link pending
v377873_ex32-2.htm Edgar Link pending